264
Views
36
CrossRef citations to date
0
Altmetric
Drug Evaluation

Stiripentol

Pages 905-911 | Published online: 15 Jul 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Alejandra Vasquez, Elaine C Wirrell & Paul E Youssef. (2023) Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam. Expert Review of Neurotherapeutics 23:4, pages 297-309.
Read now
Ana Pejčić, Slobodan M. Janković, Miralem Đešević, Refet Gojak, Snežana Lukić, Nenad Marković & Miloš Milosavljević. (2021) Novel and emerging therapeutics for genetic epilepsies. Expert Review of Neurotherapeutics 21:11, pages 1283-1301.
Read now
Francesco Brigo, Pasquale Striano, Ganna Balagura & Vincenzo Belcastro. (2018) Emerging drugs for the treatment of Dravet syndrome. Expert Opinion on Emerging Drugs 23:4, pages 261-269.
Read now
Rong Lu, Shan Liu, Qilin Wang & Xia Li. (2015) Nanoemulsions as novel oral carriers of stiripentol: insights into the protective effect and absorption enhancement. International Journal of Nanomedicine 10, pages 4937-4946.
Read now
Stanislaw J Czuczwar, Michal K Trojnar, Aleksandra Gergont, Slawomir Kroczka & Marek Kacinski. (2008) Stiripentol – characteristic of a new antiepileptic drug. Expert Opinion on Drug Discovery 3:4, pages 453-460.
Read now

Articles from other publishers (31)

Francesco Brigo, Stanley C Igwe & Nicola Luigi Bragazzi. (2022) Stiripentol add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Kenneth A. MyersIngrid E. Scheffer. (2022) Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies. Annual Review of Pharmacology and Toxicology 62:1, pages 641-662.
Crossref
Francesco Brigo, Stanley C Igwe & Nicola Luigi Bragazzi. (2020) Stiripentol add-on therapy for drug-resistant focal epilepsy. Cochrane Database of Systematic Reviews.
Crossref
Pavel Klein, Dwain Tolbert & Barry E. Gidal. (2019) Drug–drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures. Epilepsy & Behavior 99, pages 106459.
Crossref
Kenneth A Myers, Paul Lightfoot, Shekhar G Patil, J Helen Cross & Ingrid E Scheffer. (2018) Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study. Developmental Medicine & Child Neurology 60:6, pages 574-578.
Crossref
Francesco Brigo, Stanley C Igwe & Nicola Luigi Bragazzi. (2018) Stiripentol add-on therapy for focal refractory epilepsy. Cochrane Database of Systematic Reviews.
Crossref
Kelly G. Knupp & Elaine C. Wirrell. (2018) Treatment Strategies for Dravet Syndrome. CNS Drugs 32:4, pages 335-350.
Crossref
Francesco Brigo, Stanley C Igwe & Nicola Luigi Bragazzi. (2017) Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy. Cochrane Database of Systematic Reviews 2020:6.
Crossref
Katherine C Nickels & Elaine C Wirrell. (2017) Stiripentol in the Management of Epilepsy. CNS Drugs 31:5, pages 405-416.
Crossref
Basanagoud Mudigoudar, Sarah Weatherspoon & James W. Wheless. (2016) Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies. Seminars in Pediatric Neurology 23:2, pages 167-179.
Crossref
Xiu-Yu Shi, Yuko Tomonoh, Wen-Ze Wang, Atsushi Ishii, Norimichi Higurashi, Hirokazu Kurahashi, Sunao Kaneko & Shinichi Hirose. (2016) Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes. Brain and Development 38:1, pages 40-46.
Crossref
Francesco Brigo, Monica Storti & Stanley C Igwe. (2015) Stiripentol for focal refractory epilepsy. Cochrane Database of Systematic Reviews.
Crossref
Francesco Brigo & Stanley C Igwe. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Tapani Ker?nen. 2015. The Treatment of Epilepsy. The Treatment of Epilepsy 628 632 .
Xingwang Zhang, Huan Wang, Tianpeng Zhang, Xiaotong Zhou & Baojian Wu. (2014) Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug. European Journal of Pharmaceutical Sciences 62, pages 301-308.
Crossref
Arne Schousboe, Karsten K. Madsen, Melissa L. Barker-Haliski & H. Steve White. (2014) The GABA Synapse as a Target for Antiepileptic Drugs: A Historical Overview Focused on GABA Transporters. Neurochemical Research 39:10, pages 1980-1987.
Crossref
Francesco Brigo & Monica Storti. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Melissa Barker-Haliski, Graeme J. Sills & H. Steve White. 2014. Issues in Clinical Epileptology: A View from the Bench. Issues in Clinical Epileptology: A View from the Bench 295 308 .
Francesco Brigo. (2013) Pharmacodynamic interaction between stiripentol and benzodiazepines: From molecular to clinical studies. Epilepsy & Behavior 29:3, pages 586.
Crossref
Francesco Brigo, Monica Storti & Alessandra Del Felice. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Theodor W. May, Rainer Boor, Thomas Mayer, Uwe Jürgens, Bernhard Rambeck, Nils Holert, Elisabeth Korn-Merker & Christian Brandt. (2012) Concentrations of Stiripentol in Children and Adults With Epilepsy. Therapeutic Drug Monitoring 34:4, pages 390-397.
Crossref
Dezhi Cao, Hideyuki Ohtani, Ikuo Ogiwara, Sanae Ohtani, Yukitoshi Takahashi, Kazuhiro Yamakawa & Yushi Inoue. (2012) Efficacy of stiripentol in hyperthermia‐induced seizures in a mouse model of Dravet syndrome. Epilepsia 53:7, pages 1140-1145.
Crossref
Francesco Brigo & Monica Storti. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Marie-Clémence Verdier, Olivier Tribut & Danièle Bentué-Ferrer. (2012) Suivi thérapeutique pharmacologique du stiripentol. Therapies 67:2, pages 157-160.
Crossref
Kendall Nash & Joseph Sullivan. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology 774 789 .
Yushi Inoue, Yoko Ohtsuka, Hirokazu Oguni, Jun Tohyama, Hiroshi Baba, Katsuyuki Fukushima, Hideyuki Ohtani, Yukitoshi Takahashi & Shunya Ikeda. (2009) Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 50:11, pages 2362-2368.
Crossref
P. Martin & A. Berger. (2009) Antikonvulsive Behandlung erwachsener Epilepsiepatienten mit geistiger BehinderungAnticonvulsive treatment of adult, learning disabled epilepsy patients. Zeitschrift für Epileptologie 22:3, pages 170-174.
Crossref
Scott Mintzer. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 663 683 .
Susanne Schweizer & Katrin Kuhn. (2008) Stiripentol (Diacomit®) – eine neue Therapieoption zur Behandlung des Dravet-Syndroms (SMEI)Stiripentol (Diacomit®) – A new option in the treatment of Dravet syndrome (SMEI). Zeitschrift für Epileptologie 21:3, pages 135-141.
Crossref
Emilio Perucca, Jacqueline French & Meir Bialer. (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. The Lancet Neurology 6:9, pages 793-804.
Crossref
Gerd Dannhardt & Werner Kiefer. (2007) Neue Antiepileptika in der Entwicklung. Substanzen mit neuen Wirkmechanismen. Pharmazie in unserer Zeit 36:4, pages 306-310.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.